Before you sell to, join or invest in Castle Creek Biosciences, Inc.
MentionFox check on Castle Creek Biosciences, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/castle-creek-biosciences-inc-form-d-25000001
Check Castle Creek Biosciences, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Castle Creek Biosciences, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Castle Creek Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-25.
Castle Creek Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 25, 2025. The filing reports $75M sold. Its industry group is Biotechnology. It names Matthew Gantz (Executive Officer, Director), Jude Sullivan (Executive Officer), Darien Parhad (Executive Officer) (SEC Form D, February 25, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Castle Creek Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-02-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Castle Creek Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Castle Creek Biosciences, Inc., from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when Castle Creek Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Castle Creek Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Castle Creek Biosciences, Inc. →Get the full cited report on Castle Creek Biosciences, Inc.
What the filing shows about Castle Creek Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Castle Creek Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Castle Creek Biosciences, Inc.'s address as 405 Eagleview Boulevard, Exton, PA 19341.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Castle Creek Biosciences, Inc. See pricing
Castle Creek Biosciences, Inc. is a registered filer with the SEC (CIK 1756702) and has filed since 2025-02-25. 1 filing is on record, the latest on 2025-02-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Castle Creek Biosciences, Inc.'s Form D of 2025-02-25 names Matthew Gantz, Jude Sullivan, Darien Parhad and 5 more as its officers, directors or promoters.
Its new offerings report $75M sold across 1 offering, as its own filings state.
Trailing twelve months. 765 filings in Biotechnology, totalled by week.
Matthew Gantz is named as Executive Officer and Director on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
Jude Sullivan is named as Executive Officer on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
Darien Parhad is named as Executive Officer on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
Matthew Crabtree is named as Director on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
Patrick Morris is named as Director on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
Jeffrey Aronin is named as Director on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
Antonio Gracias is named as Director on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
David Brill is named as Director on the Form D that Castle Creek Biosciences, Inc. filed with the SEC on 25 February 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-02-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Castle Creek Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Castle Creek Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Castle Creek Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Castle Creek Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Castle Creek Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Castle Creek Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/castle-creek-biosciences-inc-form-d-25000001